# FDA Inspection 1304594 - Staska Pharmaceuticals, Inc. - February 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/staska-pharmaceuticals-inc/98351a0f-62de-4229-a79d-6603afa06f3c
Source feed: FDA_Inspections

> FDA Inspection 1304594 for Staska Pharmaceuticals, Inc. on February 20, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304594
- Company Name: Staska Pharmaceuticals, Inc.
- Inspection Date: 2026-02-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Kansas City District Office

## Related Documents

- [FDA Inspection 1251377 - 2024-09-18](https://www.keypedia.com/records/fda_inspections/staska-pharmaceuticals-inc/dffc723d-c5d3-4bea-8a2b-9eecceabc624)
- [FDA Inspection 1251377 - 2024-09-18](https://www.keypedia.com/records/fda_inspections/staska-pharmaceuticals-inc/d0b06e1f-6603-4ff5-adc0-1c2925e44b39)

Company: https://www.keypedia.com/companies/staska-pharmaceuticals-inc/1f0a154e-2760-411a-9de6-78da1634f8fc

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79